MXPA03000823A - Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene. - Google Patents
Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene.Info
- Publication number
- MXPA03000823A MXPA03000823A MXPA03000823A MXPA03000823A MXPA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccines
- immediate early
- early gene
- herpesvirus type
- equine herpesvirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62674800A | 2000-07-27 | 2000-07-27 | |
PCT/US2001/023612 WO2002009750A2 (en) | 2000-07-27 | 2001-07-27 | Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03000823A true MXPA03000823A (en) | 2003-09-10 |
Family
ID=24511676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03000823A MXPA03000823A (en) | 2000-07-27 | 2001-07-27 | Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1317481A2 (en) |
JP (1) | JP2004512826A (en) |
AR (1) | AR031599A1 (en) |
AU (1) | AU2001282997A1 (en) |
CA (1) | CA2417340A1 (en) |
DE (1) | DE01961753T1 (en) |
MX (1) | MXPA03000823A (en) |
NZ (1) | NZ523772A (en) |
WO (1) | WO2002009750A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1129722A1 (en) | 2000-02-17 | 2001-09-05 | Boehringer Ingelheim Vetmedica Gmbh | gM-negative EHV-mutants |
AR040601A1 (en) | 2002-07-19 | 2005-04-13 | Boehringer Ingelheim Vetmed | GM NEGATIVE EHV MUTANTS WITHOUT HETEROLOGICAL ELEMENTS |
WO2004011677A2 (en) * | 2002-07-26 | 2004-02-05 | Animal Health Trust | Viral marker |
ES2711878T3 (en) * | 2012-03-20 | 2019-05-08 | Merial Inc | Vaccine against recombinant equine herpes 1 virus containing mutated glycoprotein C and uses thereof |
CN108315487B (en) * | 2018-04-16 | 2021-06-22 | 福建省农业科学院生物技术研究所 | Primer group and kit for detecting eel herpesvirus and application of primer group and kit |
CN110885794A (en) * | 2019-10-30 | 2020-03-17 | 新疆农业大学 | Equine herpesvirus type 1 and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292653A (en) * | 1989-09-27 | 1994-03-08 | Novagene, Inc. | Equine herpesvirus 1 tk mutants |
EP0668355B1 (en) * | 1993-12-20 | 1999-04-07 | Akzo Nobel N.V. | Vaccine for the protection of horses against equine herpesvirus infection |
-
2001
- 2001-07-27 EP EP01961753A patent/EP1317481A2/en not_active Ceased
- 2001-07-27 NZ NZ523772A patent/NZ523772A/en unknown
- 2001-07-27 AR ARP010103602 patent/AR031599A1/en not_active Application Discontinuation
- 2001-07-27 DE DE2001961753 patent/DE01961753T1/en active Pending
- 2001-07-27 MX MXPA03000823A patent/MXPA03000823A/en unknown
- 2001-07-27 JP JP2002515303A patent/JP2004512826A/en active Pending
- 2001-07-27 AU AU2001282997A patent/AU2001282997A1/en not_active Abandoned
- 2001-07-27 CA CA 2417340 patent/CA2417340A1/en not_active Abandoned
- 2001-07-27 WO PCT/US2001/023612 patent/WO2002009750A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2417340A1 (en) | 2002-02-07 |
NZ523772A (en) | 2004-06-25 |
DE01961753T1 (en) | 2004-03-11 |
AU2001282997A1 (en) | 2002-02-13 |
AR031599A1 (en) | 2003-09-24 |
EP1317481A2 (en) | 2003-06-11 |
WO2002009750A2 (en) | 2002-02-07 |
JP2004512826A (en) | 2004-04-30 |
WO2002009750A3 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202885A3 (en) | Vaccines | |
HK1064958A1 (en) | Vaccine against hpv | |
NO20021833L (en) | Draft insert for insert | |
ZA200201963B (en) | Immunostimulatory nucleic acids. | |
ZA200202536B (en) | Pharmaceutical tramadol salts. | |
PL351486A1 (en) | Prrsv vaccines | |
NO20013662D0 (en) | Disposable bottle with gradually compressible design of the sidewalls, designed for reuse | |
MXPA03002906A (en) | Heater device for active substances. | |
AU3840101A (en) | Cold-adapted equine influenza viruses | |
MXPA02012791A (en) | Dds compound and process for the preparation thereof. | |
MXPA03000823A (en) | Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene. | |
GB9901254D0 (en) | Vaccines | |
PT1372712E (en) | Equine herpesvirus vaccine | |
HU229597B1 (en) | Improved dna vaccines for production-type animals | |
AU1738201A (en) | Adjuvants for nucleic acid vaccines | |
ZA200205470B (en) | Virus strains for the oncolytic treatment of cancer. | |
HUP0200560A2 (en) | Bhv-1 gene-deleted virus vaccine | |
HK1050693A1 (en) | Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them. | |
GB2367230B (en) | Baffle arrangement for animal feeder or the like | |
HUP0202389A3 (en) | Inactivated vaccine against feline calicivirus disease | |
ZA200004517B (en) | Cartridge for Setting Apparatuses. | |
EP1231266A4 (en) | Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene | |
AU3462900A (en) | Pillow the cervical for health | |
AU2001251761A1 (en) | Equine protozoal myeloencephalitis vaccine | |
MXPA01003195A (en) | Carbohydrate vaccines for viral diseases. |